Indian Official Endorses 100% Foreign Direct Investment In Pharmas
This article was originally published in PharmAsia News
Executive SummaryA key Indian official threw his support to allowing multinational drug makers to acquire Indian pharmaceutical companies
You may also be interested in...
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.